4484 related articles for article (PubMed ID: 6369594)
21. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
22. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
Mechl Z; Kopecný J
Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
[TBL] [Abstract][Full Text] [Related]
23. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
Rudolf Z; Strojan P
Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of malignant melanoma--current status].
Karg C; Garbe C; Orfanos CE
Hautarzt; 1990 Feb; 41(2):56-65. PubMed ID: 2180855
[TBL] [Abstract][Full Text] [Related]
25. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
Iavorskiĭ VV; Karaseva VV; Tokareva ZI
Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
[TBL] [Abstract][Full Text] [Related]
26. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
27. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
28. Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
Robidoux A; Gutterman JU; Bodey GP; Hersh EM
Cancer; 1982 Jun; 49(11):2246-51. PubMed ID: 7042068
[TBL] [Abstract][Full Text] [Related]
29. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
31. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
Ramseur WL; Richards F; Muss HB; Rhyne L; Cooper MR; White DR; Stuart JJ; Spurr CL
Cancer Treat Rep; 1978 Jul; 62(7):1085-7. PubMed ID: 356970
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Bedikian AY; Millward M; Pehamberger H; Conry R; Gore M; Trefzer U; Pavlick AC; DeConti R; Hersh EM; Hersey P; Kirkwood JM; Haluska FG;
J Clin Oncol; 2006 Oct; 24(29):4738-45. PubMed ID: 16966688
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of metastatic malignant melanoma localized to an extremity].
Jacobsen KD; Tausjø J; Hager B; Gundersen S
Tidsskr Nor Laegeforen; 2010 Jan; 130(1):21-4. PubMed ID: 20094118
[TBL] [Abstract][Full Text] [Related]
35. [Results of a randomized polychemotherapy study in malignant melanoma].
Fiedler H; Hetschko I; Wohlrab W; Wozniak KD; Lübbe D; Taube KM
Hautarzt; 1990 Jul; 41(7):369-74. PubMed ID: 1698185
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial.
Hofmann MA; Hauschild A; Mohr P; Garbe C; Weichenthal M; Trefzer U; Drecoll U; Tilgen W; Schadendorf D; Kaatz M; Ulrich J
Melanoma Res; 2011 Dec; 21(6):516-23. PubMed ID: 22076216
[TBL] [Abstract][Full Text] [Related]
37. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results.
Clunie GJ; Gough IR; Dury M; Furnival CM; Bolton PM
Cancer; 1980 Aug; 46(3):475-9. PubMed ID: 6994866
[TBL] [Abstract][Full Text] [Related]
38. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
[TBL] [Abstract][Full Text] [Related]
39. The influence of surgical procedure and the effect of chemotherapy on nodal and distant metastases of human malignant melanomas that have been grafted into nude mice.
Oguni A; Umeda M; Shigeta T; Takahashi H; Komori T
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):42-9. PubMed ID: 19962277
[TBL] [Abstract][Full Text] [Related]
40. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.
Abdi EA; McPherson TA; Tan YH
J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
